- Home
- CLMT vs OPK Comparison
CLMT vs OPK Comparison
Compare CLMT & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLMT
- OPK
- Stock Information
- Founded
- CLMT 1916
- OPK 2007
- Country
- CLMT United States
- OPK United States
- Employees
- CLMT N/A
- OPK N/A
- Industry
- CLMT Oil & Gas Production
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- CLMT Energy
- OPK Health Care
- Exchange
- CLMT Nasdaq
- OPK Nasdaq
- Market Cap
- CLMT 1.2B
- OPK 1.0B
- IPO Year
- CLMT 2006
- OPK 1995
- Fundamental
- Price
- CLMT $20.80
- OPK $1.64
- Analyst Decision
- CLMT Strong Buy
- OPK Strong Buy
- Analyst Count
- CLMT 4
- OPK 3
- Target Price
- CLMT $24.00
- OPK $2.75
- AVG Volume (30 Days)
- CLMT 739.7K
- OPK 4.1M
- Earning Date
- CLMT 11-08-2024
- OPK 11-07-2024
- Dividend Yield
- CLMT N/A
- OPK N/A
- EPS Growth
- CLMT N/A
- OPK N/A
- EPS
- CLMT N/A
- OPK N/A
- Revenue
- CLMT $4,216,399,999.00
- OPK $711,408,000.00
- Revenue This Year
- CLMT N/A
- OPK N/A
- Revenue Next Year
- CLMT $6.99
- OPK $0.50
- P/E Ratio
- CLMT N/A
- OPK N/A
- Revenue Growth
- CLMT 0.30
- OPK N/A
- 52 Week Low
- CLMT $9.97
- OPK $0.85
- 52 Week High
- CLMT $25.29
- OPK $1.75
- Technical
- Relative Strength Index (RSI)
- CLMT 51.58
- OPK 64.63
- Support Level
- CLMT $19.61
- OPK $1.37
- Resistance Level
- CLMT $22.84
- OPK $1.71
- Average True Range (ATR)
- CLMT 1.36
- OPK 0.09
- MACD
- CLMT -0.16
- OPK 0.02
- Stochastic Oscillator
- CLMT 55.58
- OPK 79.41
About CLMT Calumet Specialty Products Partners L.P. Common Units
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.